GlassScriptPhysician profile
William T Wagner
NPI 1861053050
$2,625.94
in general payments reported to CMS, 2019-2025
19 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $120 · 2021: $328 · 2022: $484 · 2023: $181 · 2024: $645 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $601.64 | 2021-2024 | Omni Surgical System |
| Alcon Vision LLC | $548.65 | 2019-2025 | Clareon, Tryptyr, Hydrus Microstent |
| Biotissue Holdings INC. | $274.55 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $269.95 | 2024-2025 | Eylea Hd, Eylea |
| Alimera Sciences, INC. | $140.97 | 2023 | Iluvien |
| Allergan, INC. | $99.99 | 2020 | |
| Glaukos Corporation | $84.55 | 2025 | Idosetr |
| Apellis Pharmaceuticals, INC. | $82.34 | 2024-2025 | Syfovre |
| Takeda Pharmaceuticals U.S.A., INC. | $82.22 | 2023-2024 | Gattex |
| Bausch & Lomb Americas INC. | $70.33 | 2024-2025 | Envista Envy Iol, Vyzulta, Miebo |
| Abbvie INC. | $69.40 | 2024-2025 | |
| Lkc Technologies, INC. | $66.34 | 2025 | |
| Astellas Pharma US INC | $66.21 | 2024-2025 | Izervay |
| Dompe US, INC. | $43.29 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $38.01 | 2025 | Xdemvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $25.50 | 2025 | Vabysmo |
| Oyster Point Pharma, INC. | $22.77 | 2025 | Tyrvaya |
| Integra Lifesciences Corporation | $20.87 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Harrow Eye, LLC | $18.36 | 2025 | Triesence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.